-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Thematic Analysis
Cloud Computing in Construction – Thematic Intelligence
Cloud Computing in Construction Market Overview The cloud computing revenues in the construction industry was valued at USD 20.8 billion in 2021 and is expected to grow at a CAGR of more than 16% between 2021 and 2026. This strong market growth will be particularly driven by the greater adoption of digitally transformative technologies across the industry, particularly with the focus on increasing efficiency and reducing the costs of business and project operations. Digitalization has been slow in the construction...
-
Analyst Opinions
Beyond Crypto – How Blockchain Advances in the Enterprise
Enterprise Blockchain Report Overview Enterprise blockchain is a “permissioned” blockchain and is made up of encrypted records (blocks). They are chronologically arranged and serve as a singular information source across a distributed network. The data within the network is accessible to a small group of network members. Security, traceability, transparency, and efficiency are the key benefits of blockchain. Blockchain Value Chain Analysis Buy the Full Report for More Insights into the Value Chains of Blockchain Download a Free Report Sample...
-
Sector Analysis
Contract Injectable Packaging Trends in the Bio/Pharma Industry
Injectables and their packaging requirements are very important to marketed treatments given the volume of vaccines required to tackle the COVID-19 pandemic and the rising number of biologics in development pipelines and on the market. Most injectable drugs in the development pipeline are biologics, which will become increasingly approved and more established in the treatment landscape in the future. The top contract packaging organizations (CPOs) for injectables by the number of contracts are standalone packagers along with large CMOs which...
-
Sector Analysis
COVID-19: Contract Pharmaceutical Development and Manufacturing Relationships
This report examines contract manufacturing agreements for vaccines and therapies targeting COVID-19. It reports that there are more than 1,000 vaccines and therapies in development for COVID-19, and 36 vaccines and therapies approved (or granted emergency use authorization) for COVID-19 (as of report publication). At the beginning of the pandemic, slightly more than half of these agreements were for vaccines; this proportion has risen and continues to rise, as several vaccines have proven their safety and efficacy, received approval, and...
-
Product Insights
Paroxysmal Nocturnal Hemoglobinuria Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Paroxysmal Nocturnal Hemoglobinuria Global Clinical Trials Review, H1, 2018" provides an overview of Paroxysmal Nocturnal Hemoglobinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Paroxysmal Nocturnal Hemoglobinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H1, 2018
GlobalData's clinical trial report, “Porphyria (Erythropoietic Protoporphyri) Global Clinical Trials Review, H1, 2018" provides an overview of Porphyria (Erythropoietic Protoporphyri) clinical trials scenario. This report provides top line data relating to the clinical trials on Porphyria (Erythropoietic Protoporphyri). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Hemoglobinuria Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H2, 2017" provides an overview of Hemoglobinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Hemoglobinuria Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Hemoglobinuria Global Clinical Trials Review, H1, 2016" provides an overview of Hemoglobinuria clinical trials scenario. This report provides top line data relating to the clinical trials on Hemoglobinuria. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...